Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Joseph Jarvis

Has grant

Professor of Tropical Medicine and International Health

London School of Hygiene & Tropical Medicine

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Recent Grants

Grant: Close

Global Health Group on HIV-associated fungal infections

Open Date: 2022-08-01

Close Date: 2026-08-01

Grant: Close

EDCTP-TDR Clinical Research and Development Fellowship

Open Date: 2022-01-01

Close Date: 2024-01-01

Grant: Close

Implementing novel short-course treatment regimens for HIV-associated Cryptococcal meningitis in sub-Saharan Africa

Open Date: 2021-09-01

Close Date: 2026-09-01

Grant: Close

Integrated Cryptococcal and opportunistic infection management to improve outcomes in Advanced HIV Disease

Open Date: 2021-04-01

Close Date: 2025-04-01

Grant: Close

Fluconazole plus flucytosine vs fluconazole alone for cryptococcal antigen-positive patients identified through screening: A randomised trial

Open Date: 2021-04-01

Close Date: 2025-04-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

Professor

City, University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joseph Jarvis

Research Interests

Explore related searches

Recent Grants

Articles (20)

Once-Daily Dolutegravir–Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial

Cytomegalovirus viraemia is strongly associated with 6-month mortality amongst adults living with advanced HIV disease: a prospective cohort study in South Africa

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial

When the Evidence Aligns: Single-Dose Liposomal Amphotericin B for Cryptococcal Meningitis in High-Income Settings

Detection of hepatitis B virus in cerebrospinal fluid of people with HIV-associated cryptococcal meningitis in Botswana.

Under pressure: a call to increase access to spinal manometers as a critical component of the management of cryptococcal meningitis.

Long-Acting Treatment and Advanced HIV Disease — Addressing a Public Health Priority

Integrating hypertension care into the existing HIV services package in Botswana (InterCARE): a pair-matched, cluster-randomised, type 2 hybrid effectiveness-implementation trial.

Ten years on: Ongoing challenges in screening for cryptococcal antigenaemia in people with advanced HIV disease in South Africa

Advanced HIV disease.

Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice.

Cause of Death and Risk of Death for People Living With HIV Admitted to Hospital: A Systematic Review and Meta-Analysis.

Cytomegalovirus Viremia in Advanced HIV Disease

Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.

High Prevalence of Hepatitis B Virus Infection Among People Living with Advanced HIV Disease in Botswana.

Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS.

Comparative analysis of glucuronoxylomannogalactan (GXMGal) and glucuronoxylomannan (GXM) antibody responses and their associations with cryptococcal disease status in people living with HIV

Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study

Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges.

Collaborators (12)

Nei-yuan Hsiao

Graeme Meintjes

Ronan Doyle

David Moore

Vanessa Yardley

Angela Loyse

Katharine Stott

Melanie R Nicol

Síle Molloy

James Milburn

Daniel Grint

Thomas Harrison

Make your next move.